Sharmila Masli Selected Research

Iris Diseases

3/2014	Determining immune components necessary for progression of pigment dispersing disease to glaucoma in DBA/2J mice.
4/2008	GpnmbR150X allele must be present in bone marrow derived cells to mediate DBA/2J glaucoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sharmila Masli Research Topics

Disease

15	Inflammation (Inflammations) 01/2021 - 04/2004
8	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022 - 09/2009
4	Hypersensitivity (Allergy) 01/2019 - 01/2008
3	Uveitis 05/2022 - 06/2008
3	Corneal Neovascularization 05/2011 - 04/2004
2	Autoimmune Diseases (Autoimmune Disease) 12/2016 - 02/2016
2	Iris Diseases 03/2014 - 04/2008
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 03/2005 - 06/2002
1	Pterygium 08/2021
1	Pathologic Processes 01/2019
1	Keratitis 01/2019
1	Disease Progression 01/2018
1	Sjogren's Syndrome (Sjogren Syndrome) 12/2016
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 10/2014
1	Keratoconjunctivitis 07/2014
1	Glaucoma 03/2014
1	Neoplasms (Cancer) 09/2009
1	Necrosis 05/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2009
1	Leukostasis 03/2009

Drug/Important Bio-Agent (IBA)

14	Thrombospondin 1IBA 05/2022 - 04/2004
4	CytokinesIBA 08/2020 - 07/2014
3	Peptides (Polypeptides)IBA 05/2022 - 09/2015
3	Retinaldehyde (Retinal)IBA 05/2022 - 03/2005
3	AntigensIBA 09/2009 - 06/2002
3	Transforming Growth Factor beta (TGF-beta)IBA 05/2009 - 03/2005
2	ThrombospondinsIBA 05/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 08/2020 - 09/2015
2	LigandsIBA 01/2019 - 06/2008
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2014
2	Glycoproteins (Glycoprotein)IBA 07/2014 - 06/2008
2	EndotoxinsIBA 03/2009 - 06/2008
2	P-SelectinIBA 03/2009 - 06/2008
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2022
1	interstitial retinol-binding proteinIBA 05/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Messenger RNA (mRNA)IBA 08/2021
1	DNA (Deoxyribonucleic Acid)IBA 08/2021
1	FlagellinIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 08/2020
1	Growth Factor ReceptorsIBA 01/2019
1	Extracellular Matrix ProteinsIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	IntegrinsIBA 02/2016
1	GW559090IBA 02/2016
1	Fluorescein (Funduscein)FDA LinkGeneric 02/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2016
1	Scopolamine (Hyoscine)FDA Link 09/2015
1	MucinsIBA 10/2014
1	dexamethasone 21-phosphate FDA LinkGeneric 04/2011
1	Fluorometholone (FML)FDA Link 04/2011
1	prednisolone acetate FDA LinkGeneric 04/2011
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009
1	Type II Tumor Necrosis Factor ReceptorsIBA 05/2009
1	Monoclonal AntibodiesIBA 03/2009
1	P-selectin ligand proteinIBA 03/2009
1	LipopolysaccharidesIBA 03/2009
1	Interleukin-18 (Interleukin 18)IBA 04/2008
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2006
1	Retinal Pigments (Pigments, Visual)IBA 09/2006
1	OvalbuminIBA 03/2005
1	AntibodiesIBA 06/2002
1	Complement System Proteins (Complement)IBA 06/2002

Therapy/Procedure

2	Sutures (Suture) 04/2011 - 04/2004
1	Corneal Transplantation (Keratoplasty) 01/2019
1	Injections 09/2015
1	Refractive Surgical Procedures 07/2014
1	Microspheres (Microsphere) 06/2008
1	Lasers (Laser) 06/2008